The ANCOVA revealed that there were significant effects of BD diagnosis on the levels of C3a and C5a after co-varying for BMI, smoking, chlorpromazine equivalent dosage and mood stablizer dosage (Table 3). This evidence concerns the gene C5AR1 and Behcet disease.